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ABSTRACT
The assessment model for ultraviolet radiation and risk
“AMOUR” is applied to output from two chemistry-climate
models (CCMs). Results from the UK Chemistry and Aero-
sols CCM are used to quantify the worldwide skin cancer
risk avoided by the Montreal Protocol and its amendments:
by the year 2030, two million cases of skin cancer have been
prevented yearly, which is 14% fewer skin cancer cases per
year. In the “World Avoided,” excess skin cancer incidence
will continue to grow dramatically after 2030. Results from
the CCM E39C-A are used to estimate skin cancer risk that
had already been inevitably committed once ozone depletion
was recognized: excess incidence will peak mid 21st century
and then recover or even super-recover at the end of the cen-
tury. When compared with a “No Depletion” scenario, with
ozone undepleted and cloud characteristics as in the 1960s
throughout, excess incidence (extra yearly cases skin cancer
per million people) of the “Full Compliance with Montreal
Protocol” scenario is in the ranges: New Zealand: 100–150,
Congo: 10–0, Patagonia: 20–50, Western Europe: 30–40,
China: 90–120, South-West USA: 80–110, Mediterranean: 90
–100 and North-East Australia: 170–200. This is up to 4% of
total local incidence in the Full Compliance scenario in the
peak year.
INTRODUCTION
Ultraviolet radiation (UV) from the sun can induce skin cancer.
Assuming sun exposure behavior does not change, more UV will
induce more skin cancer. Using chloroﬂuorocarbons (CFCs) and
related substances (from here we will use the term ODS: ozone-
depleting substance), human civilization has compromised the
ozone layer that protects against harmful solar UV reaching
Earth’s surface (1–7). As a consequence, society has to face a
health risk: excess cases of skin cancer (and cataract) compared
with a situation of unperturbed ozone layer. Fortunately, sus-
tained depletion of the ozone layer is expected to have been
averted by the Montreal Protocol, of which the amendments are
expected to have paved the way for full ozone recovery (8–10).
This study aims to answer the following questions: How much
skin cancer risk has been avoided by the Montreal Protocol?
How much risk have we already been inevitably committed to
once the problem of ozone depletion was recognized?
There are delays within the climate system, and there is a time
lag from sun exposure to skin cancer development. By conse-
quence, burden of health consequences linked to anthropogenic
ODS emissions is not directly measurable today. Firstly, even
when the production of ODSs is stopped, ODSs will still be
emitted to the atmosphere from their banks (discarded applica-
tions). Secondly, even when ODSs will not be emitted anymore,
the removal of ODSs from the atmosphere will take a substantial
amount of time. Finally, people may develop skin cancer from
raised UV levels they received earlier in their life, long after the
recovery of the ozone layer and the UV levels. Instead of
directly measuring the health risk associated with the production
and emission of ODSs, we have to take all these time lags into
account when formulating impact models.
In 1985, the Vienna Convention for the Protection of the
Ozone Layer was agreed upon. It provided a framework for
international efforts to protect the ozone layer. These efforts
resulted in legally binding targets to ban ODSs, formulated in
the Montreal Protocol, which was signed in 1987, with amend-
ments in 1990, 1992, 1995, 1997, 1999 and 2005 (9). A true
recovery of the ozone layer did not come within reach until the
Copenhagen amendments in 1992.
In 1996, Slaper et al. (11) showed the health risk associated
with different scenarios for ozone depletion. The analysis was
based on trend analysis of satellite observations of the ozone
layer from 1979 to 1991. They estimated the additional risk of
skin cancer for people with white skin in Europe and the United
States of America for different ODS-production scenarios. They
found a quadrupling of skin cancer incidence for the No-Protocol
scenario by the year 2100. This was reduced to a doubling in
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2100 for the Montreal Protocol scenario (without amendments),
and even further reduced to a peak of 10% increase around 2060
for adherence to the Copenhagen Amendments.
Based on Slaper et al. (11), the assessment model for ultra-
violet radiation and risk (AMOUR) was developed at the Dutch
National Institute for Public Health and the Environment
(RIVM): a utility suite to analyze different aspects of the produc-
tion of ODSs to health-risk chain (12–15). In the past years, not
only negative effects from exposure to solar UV radiation
acquire attention but also positive ones: some UV is important
for the formation of vitamin D in the skin, see e.g. (16). Vitamin
D is important for bone strength and might help to prevent certain
forms of cancer.
Since the study by Slaper et al. (11), coupled chemistry-cli-
mate models (CCMs) have advanced. They now fully incorporate
the coupled nonlinear processes involved in the dynamics of the
ozone layer (17–21). There is no need for ad hoc parameteriza-
tions. Recently, Newman and McKenzie (22) presented CCM-
based estimates for the health impact of the Montreal Protocol.
They reported a huge beneﬁt from the Montreal Protocol for skin
cancer and only minor impact on vitamin D. They also con-
cluded that improvements of the representation of climate-rele-
vant processes in the CCMs may lead to different results.
In this study, we start with an exploration of the “Full Com-
pliance” scenario, the best estimate given by the WMO for pro-
duction and emission of ODSs from 1900 until the end of the
21st century (scenario A1 from [8]). We start with a description
of the development of the ozone layer as derived from E39C-A,
see (19,20) for details, followed by a description of the associ-
ated development of clouds. The AMOUR utility-suite is then
used to calculate worldwide maps for the available UV dose and
a scenario for skin cancer. Conclusions forthcoming from
AMOUR calculations can be used to anticipate at future develop-
ments, e.g. in public health care. For the rest of this study, the
combination of the AMOUR tool-suite and the CCM E39C-A
will be denoted as E39C-A.
Subsequently, we make an estimate of what the world would
have looked like had the Montreal Protocol not been signed: the
“World Avoided.” Results of the CCM UKCA (17,18) are used
to construct two sets of maps for total column ozone. One set is
made by ﬁtting a stationary effective stratospheric chlorine load
of 9 ppbv, the load according to the WMO “No-Protocol” sce-
nario in the year 2030. For the other set of ozone maps, which
serves as a reference, a stationary chlorine load of 3.5 ppbv is
used, approximately the chlorine loading in 2000, the year of the
strongest ozone depletion. The AMOUR tool-suite is taken to
estimate the associated UV climate and health risk avoided by
the Montreal Protocol when compared with the reference sce-
nario. The combination of the AMOUR tool-suite and the CCM
UKCA will from now on be denoted as UKCA. This study ends
with a discussion of results and a brief conclusion of which
worldwide risk has been avoided by the Montreal Protocol and
which risk has been committed nevertheless in the “Full Compli-
ance” scenario. The Montreal Protocol protects life on Earth.
How many lives have actually been saved by this agreement?
Combination of our population scenario with skin cancer
incidence data from Parkin et al. (23) shows that by the year
2100, skin cancer incidence will be doubled in Europe and the
United States of America and tripled worldwide as a consequence
of aging alone. The focus of this study is on human interference
with the environment and associated health impact. Therefore,
this study will not address the effects of aging separately. The
effects of aging will be largely eliminated by the presentation of
“excess risks,” the difference in risk between a scenario and a
reference scenario that uses the same, aging population scenario.
A similar reasoning applies to behavior. Pitcher and Longstreth
(24) have analyzed cohort data collected from 1950 to 1979 for
white people in the United States of America. They found that
different cohorts have different melanoma mortality characteris-
tics, showing that the construction of a health-risk scenario
requires the inclusion of a behavioral component. The observed
growth in skin cancer incidence is probably attributable to
increased exposure. To allow for zooming in on the effects of
ozone depletion, the population in the reference scenario should
abide to the same behavior as in the scenario at hand. This is
achieved by assuming that the UV dose received is a ﬁxed frac-
tion of the available UV-dose. In reality, exposure depends on
behavior and behavior depends on climate, the weather, age, gen-
der and culture. This aspect, like aging, was beyond the scope of
this study.
METHODS FOR THE “FULL COMPLIANCE”
SCENARIO
Climate model E39C-A
The reference model E39C consists of the dynamic part ECHAM4.
L39(DLR) and the chemistry module CHEM. ECHAM4.L39
(DLR) is a derivate of the climate model ECHAM4, with an
enhanced vertical resolution from 19 to 39 levels where the upper-
most level is centered at 10 hPa. In E39C-A, the Lagrangian advec-
tion scheme ATTILA replaced the former semi-Lagrangian scheme
in E39C, leading to large improvements in the model performance
(19). The model is run with a horizontal spectral resolution of T30,
corresponding to ca 3.75° 9 3.75° on the transformed Gaussian
grid. The chosen time step is 24 min. The chemistry module
CHEM is based on the family concept, including stratospheric
homogeneous and heterogeneous ozone chemistry and the most
relevant chemical processes for describing the tropospheric back-
ground chemistry. More details on the model are found in (19).
In this study, the SCNB2d simulation performed with E39C-
A is used. The simulation spans from 1960 to 2049, and both
anthropogenic and natural forcing are prescribed based on obser-
vations for the past and on future projections for the future.
Greenhouse gas concentrations are prescribed according to the
A1B scenario, and ODS concentrations are prescribed for a
future scenario as expected considering the Montreal protocol
(and amendments). The simulation is described in detail in (20).
Ozone
Every 12 h, a worldwide ozone map is generated with a resolu-
tion of 3.75° 9 3.75° (96 9 48 nodes). Apart from ozone maps,
maps were generated for surface albedo, net shortwave radiation
and snow cover. At the poles, the strongest ozone depletion of
the year occurs in (local) spring, when the rising sun sublimates
the ice crystals, thus releasing the collected ODS.
Clouds
The dose of solar UV radiation at the Earth’s surface largely
depends on cloud cover. Den Outer et al. (25) have shown that
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for European stations two-thirds of the change in total UV dose
is attributable to a decline in cloud cover. We use the cloud
modiﬁcation factor (CMF) as a measure for cloud impact. This is
the ratio of irradiance under real cloud conditions to that under
cloud-free skies. The CMF is nearly zero for overcast thick
clouds and is equal to one for cloud-free conditions. It includes
the effects of both cloud optical depth and cloud cover.
E39C-A produced maps of cloud fraction and net shortwave
radiation at the surface for clear-sky and for all-sky (i.e. includ-
ing clouds) conditions. The two estimates for the net shortwave
radiation were used to estimate the CMF for total solar radiation.
The method of Den Outer (26–28) has been applied to convert
this CMF for all incoming solar radiation to a CMF for UV
alone. The method is a parameterization for different solar zenith
angles based on pairs of observations for cloud reduction for
total (global) radiation and for UV.
UV
UV calculations were made with AMOUR’s radiative transfer
model based on TUV (29). UV was weighted with the SCUP_h
action spectrum for human skin cancer, which differs subtly from
the erythemal action spectrum, see (30). The ozone- and surface-
albedo ﬁelds of E39C-A are used to estimate clear-sky SCUP_h-
weighted UV dose maps on a worldwide 1° 9 1° grid. The
domain grid was selected to accommodate earlier calculations
made with AMOUR and to connect to the available population
scenario. For each grid cell, the cloud-corrected UV dose has
been calculated with time steps of 15 min, and integrated to a
monthly dose. The monthly doses have been aggregated to
yearly doses.
Risk: new cases of skin cancer
AMOUR includes a worldwide population scenario for the per-
iod 1900–2100. Country-speciﬁc information for a medium-fertil-
ity population development scenario from (31–33) has been
combined with the LandScan High Resolution global Population
Data Set for 2002 (34), aggregated to 1°9 1°. This has resulted
in a set of 1° 9 1° gridded maps of population for 17 age
cohorts for ages 0–4, 5–9, etc. for the years 1900–2100.
The risk at three types of skin cancer, basal cell carcinoma
(BCC), squamous cell carcinoma (SCC) and cutaneous mela-
noma (CM), is estimated with the dose–effect relations from
Slaper et al. (11). These relations, derived for white skin in
Western Europe and the United States of America, are given in
the Appendix. There it is also explained how we made them
globally applicable and thereby ﬁt for the present analysis, by
taking into account differences in sensitivity for UV. Even
though the ozone scenario from E39C-A stopped at 2050, our
risk analysis with E39C-A was extended to the year 2100. Our
assumption that after 2049 the annual UV dose will remain con-
stant will not have affected our results for the second half of
the 21st century signiﬁcantly, ﬁrstly since in this period of time,
according to the scenario at hand, depletion of the ozone layer
is largely compensated for and secondly because exposure in
the second half of the 21st century is not dominant for the risk
in this same period: in average sense, there are several decades
of delay between the induction of DNA damage by ultraviolet
radiation and the expression of the associated mutations in skin
cancer.
To demonstrate the health impact of the “Full Compliance”
scenario, we compare the associated development of skin cancer
incidence with that for a reference scenario. The difference in
incidence between a scenario and the reference scenario is called
the excess incidence. For the reference, it is assumed that, for
the whole period considered, both ozone layer and clouds have
been and will be unaffected (by both natural and human interfer-
ence). This means unaltered and stationary ozone- and cloud cli-
mate, with only an annual cycle. This “No Depletion” scenario
has been based on the 10-year mean annual dose from 1960 to
1969, as estimated with E39C-A. The population scenario for
the reference run is the same as for the full E39C-A run.
METHODS FOR THE “WORLD AVOIDED”
SCENARIO
Unlike with the “Full Compliance” scenario, we do not make a
dynamical analysis of the “World Avoided” scenario. Instead,
two time slices for (ozone maps of) the Earth are created for
10 years with different effective, stratospheric chlorine loads:
one for the year 2000, with a load of 3.5 ppbv and one for
9 ppbv, the load projected by WMO for about the year 2030 if
the Montreal Protocol had not been implemented. The health
damage that would be caused by the latter scenario would
develop explosively, albeit with the earlier mentioned delay of
some decades after exposure to the harmful UV. Newman et al.
(35) tried to make such a dynamical run with a climate model to
about 2060 with exponentially increasing chlorine. After a while,
the stratosphere contained so little ozone, that the model was not
prepared to handle the extreme condition and gave up. These are
the reasons why we have not made a dynamical scenario analysis
to estimate the gain made by the Montreal Protocol.
Climate model UKCA
The UKCA model is based on the Met Ofﬁce Uniﬁed Model
(MetUM). The model is run at a resolution of 3.75 9 2.5°
(96 9 73 grid nodes) with 60 hybrid height levels in the verti-
cal, extending to 84 km. There is a representation of nonoro-
graphic gravity waves. AMIP2 sea-surface temperatures (SSTs)
and sea ice are prescribed from the period September 1989 to
August 1999. Ocean feedback is important to climate, especially
on long timescales. We focus here on relatively short periods (ca
three decades) where the limitation of using prescribed SSTs is
less serious. We have added to the MetUM a stratospheric chem-
istry scheme. We use a nonfamilies solver and prescribe sulfate
aerosol surface area densities. Two runs are made with the
UKCA model: a reference run, using the present-day chlorine
loading of 3.5 ppbv, and a “World-Avoided” run, using 9 ppbv
of chlorine, the concentration corresponding to the no-protocol
scenario in the year 2030. Both simulations assume a contem-
porary bromine loading of 20 pptv. For chemistry, long-lived
tracers and halogen source gases are given uniform and time-
invariant lower boundary conditions representative for the 1990s,
except for the CFCs, which are increased in the 9 ppbv simula-
tion. For radiation, time- and spatially invariant ﬁelds (identical
in the two simulations) are assumed for all greenhouse gases
except O3 and H2O, with numbers representative of the 1990s.
The same SSTs and the same radiative forcing due to greenhouse
gases (including CFCs) was assumed in both runs, implying that
climate change has not been factored in. The present-day run
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compares well with observations. Details of the model are
described in reference (17,18).
Ozone and clouds
For the construction of ozone ﬁelds, data derived from the CCM
UKCA are used just like E39C-A. The maps produced in this way
are worldwide with a resolution of 3.75°9 2.5° (96 9 73 nodes)
and estimated for each month in a period of 10 years. Cloud
impact and surface albedo were not estimated by UKCA. Instead,
we used climatologic estimates for cloud impact and surface albedo
for each month of the year, on basis of satellite observations.
UV
For both UKCA model runs, monthly and yearly worldwide,
SCUP_h-weighted irradiance maps are constructed with a 1°91°
resolution, in the same manner as carried out for the Full Com-
pliance scenario. For each run, the 10-year dose maps were
aggregated to get a mean year dose estimate.
Risk
We estimated how many new cases of skin cancer would appear
annually in the respective scenarios. This was done on basis of the
yearly UV irradiance dose maps in the same way as for the Full
Compliance scenario. Seventeen age cohorts are discriminated
with cohort width of 5 years for people in age from 0 to 85 year.
There were no UKCA-model estimates for the thickness of the
ozone layer before 1980, the era in which the dose contributions
were received that dominate the reference incidence numbers with
which the dose–effect relations are calibrated. To overcome this
lack of information, the ratio of the UV dose in 1980 and in 2009
for the Netherlands is estimated using AMOUR with total ozone
measurements from satellites (dose ratio 0.92) and this ratio is
used as a basis for a correction factor in the dose–effect relations.
The resulting age-speciﬁc incidence maps are combined for three
types of skin cancer with the age-speciﬁc population maps for the
year 2030 from the population scenario presented by Struijs et al.
(15), to estimate the total difference in skin cancer incidence. In
this analysis, the reference is formed by the UKCA model with
stratospheric chlorine load for the year 2000. This is near 1995,
the time when total column ozone in the real world, following the
Full Compliance scenario, reached its minimum. The use of this
reference makes our excess risk estimates into conservative esti-
mates for the excess risk for the World Avoided scenario when
compared with the Full Compliance scenario.
RESULTS FOR THE “FULL COMPLIANCE”
SCENARIO
Ozone
Figure 1 shows modeled time series for total column ozone for
local spring (October for the southern hemisphere, April for the
northern hemisphere), averaged over zonal bands with a band-
width of 11.25° (eight bands for the southern hemisphere).
Ozone values derived from E39C-A show a high bias of about
50 DU, but the general features and behavior are in agreement
with observations (see [21] and [36] for a speciﬁc discussion
about the bias). We have not renormalized ozone estimates from
E39C-A to match satellite observations because E39C-A is
highly nonlinear. This means that ozone ﬁelds that would be
matched to observations, either by multiplication with a correc-
tion factor or by subtraction of a ﬁxed term, would not be con-
sistent with the climate model anymore.
Two dotted lines are added in Fig. 1, one for the zonal band
on the southern hemisphere with the highest column ozone
(51°) and one for the band with the lowest column ozone
(84°). These curves were constructed using the method used
by Slaper et al. (11), which combines a trend analysis of global
satellite-based measurements for 1980–1990 with parameteriza-
tions of dynamical effects in the ozone layer for the remaining
period 1991–2100. The ﬁrst thing to notice is the good qualita-
tive agreement. The time when the Antarctic ozone hole will
start its recovery matches: for both solid (present analysis) and
dotted (1996 method) lines, depletion is at its worst around
1995. The E39C-A results suggest an earlier recovery of the
ozone layer than suggested by Slaper. For the extra-polar
regions, this can be the result of the inclusion of climate change
in E39C-A. Increasing greenhouse gas (GHG) concentrations in
the model lead to stratospheric cooling and thus a slowdown of
the catalytic reactions for ozone destruction. Over Antarctica,
additional cooling will promote ozone depletion as more polar
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Figure 1. Modeled total column ozone for local spring in the Full Compliance scenario according to E39C-A (left: October, southern hemisphere; right:
April, northern hemisphere). Total column ozone has been averaged over 11.25° zonal bands (midpoint latitude is shown). Dotted lines give the ozone
scenarios for latitude bands 84° and 51° based on the method used by Slaper et al. (11) and calibrated with the (modeled/observed) total column
ozone estimates from 1980 to 1990 from the respective models.
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stratospheric clouds (PSC) will form, overcompensating the
slowdown of gas-phase ozone depletion which follows the heter-
ogeneous chlorine activation on PSCs. E39C-A simulates the
temporal and latitudinal structure of the ozone hole until 2010
mostly in agreement with observations (37), but the return date
is earlier than in most other models.
Clouds
In Fig. 2, the zonally averaged CMF for UV in June (summer)
and December (winter) for eight bands on the northern hemi-
sphere is presented. The curves have been smoothed with a
5 year central moving average (boxcar ﬁlter). There is a general
tendency for the CMF to either remain (stochastically) stationary
or to gradually drop to lower values, which means “stronger
cloud-impact.” The largest change in CMF is observed in
December for the 62° latitude band: from 0.7 in the year 1960 to
0.58 in the year 2049, a decrease of 17%. Trends in CMF from
E39C-A in summer are less manifest than in winter. The June
graph for the 51° latitude band shows an increase in cloud trans-
mission, the others do not show a change or a decline.
UV
According to analysis with E39C-A of the “Full Compliance”
scenario, ozone in the northern hemisphere will recover to 1980
values between 2010 and 2020, whereas at the same time, clouds
will tend to have a stronger reducing effect on UV radiation. To
assess which of these two effects is dominant, time series of
clear-sky and cloud-corrected zonally averaged annual UV radia-
tion are presented in graphs (a) and (b) in Fig. 3, relative to the
annual UV dose in 1960. Graph (c) depicts the isolated develop-
ment of the cloud impact compared to the cloud impact of 1960
(the ratio of the second graph to the ﬁrst graph). It shows that
cloud impact will remain more or less the same for the zone
from latitude 20 to 50°N, but in the tropics and north of 50°N
latitude, clouds will transmit increasingly less UV. Curves in
Fig. 3c show some scatter, but this trend is manifest over the full
time domain. The development of UV radiation under clear sky,
in graph 3(a), reﬂects the associated temporal development in the
ozone layer shown earlier in Fig. 1: initially, ozone depletion
will lead to more UV for the midlatitudes and near the poles
(1970–2000). Subsequently, ODSs will leave the stratosphere
and allow for a restoration of the ozone layer. Enhanced green-
house gas concentrations will cool down the stratosphere and
induce recovery (and above) of the ozone layer and reduce UV
to smaller than 1980 levels. The impacts on UV change from
ozone and from clouds are comparable in magnitude.
Uncertainty analysis of UV climate
Recently (10,37), “Full Compliance” scenarios for ozone and
UV radiation climate have been presented for an ensemble of
CCMs, including E39C-A and UKCA, the models used in our
analysis. For the northern midlatitudes, Fig. 2–6 in the UNEP/
WMO Scientiﬁc Assessment of Ozone Depletion 2010 (10) sug-
gests recovery of the ozone layer to undisturbed conditions
between 2016 and 2026 (±2r range), with an ensemble spread
from 2008 to 2050. For the midlatitudes on the southern hemi-
sphere, ozone recovery is estimated to come about a bit later:
between 2030 and 2040 (ENSEMBLE spread from 2012 to
2048). In the ensemble of CCMs, E39C-A shows a relatively
early return of ozone to recent (undisturbed) levels. This differ-
ence may be related to the location of the upper model boundary,
which is centered at 10 hPa, whereas the majority of CCMs
reach up to the mesosphere (0.01 hPa). The ozone bias of about
+50 DU in the E39C-A results, will induce a systematically
attenuated UV climate.
Estimates of shortwave radiation at the surface provided by
CCMs, both under clear- and all-sky conditions, are approxima-
tions because they are computed from a broadband radiative
transfer model. This approach has not been exhaustively evalu-
ated, particularly with respect to the description of clouds ([20]
chapter 3, [38]). According to Bais et al. (37), the CMF calcula-
tions depend less on the accuracy of the radiation schemes
employed in the CCMs, and more on how clouds and their
effects on radiation are represented in each model. The uncertain-
ties in the CMF deduced by E39C-A are expected to be similar
to those in other models discussed in Bais et al. (37); however,
no clear statements can be made about the quality of E39C-A
results with respect to cloud effects. In that study, it is concluded
that: “Cloud effects are responsible for 2–3% of the reduction in
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Figure 2. Zonal mean cloud modiﬁcation factor for the Full Compliance scenario from E39C-A for UV for the months June (a) and December (b) for
the northern hemisphere. The number in the legend refers to the mean latitude in [°] of the zonal band.
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erythemal UV at high latitudes, but they slightly moderate it at
midlatitudes (ca 1%).” Both the ensemble of CCMs and the spe-
ciﬁc model that have been used indicate a trend (1960–2100) in
cloud impact (“more cloud”) that is in the opposite direction
when compared with the observational results (1980–2006)
reported by Den Outer et al. (25) (“less cloud”). The 2011 report
from the UNEP (16) indicated that cloud cover would increase at
northern high latitudes (and UV decrease), but would be less in
the tropics (and thus a UV increase).
Risk: new cases of skin cancer
Estimates for excess total skin cancer incidence are given for
eight regions shown in Fig. 4: New Zealand, Patagonia, Congo,
China, North-East Australia, Mediterranean, South-West USA
and West Europe. These regions have been selected to demon-
strate the variety of our results for different populations. Regions
were selected such that intraregional variation in the population
(which itself was modeled to be a composite of different ethnic
groups) was small and that variation in latitude (and therefore
UV-dose) would not dominate intraregional variance in risk. See
the Appendix for details on the population scenario.
In Fig. 5, the excess total incidence is shown for the sum of
three types of skin cancer in the Full Compliance scenario. All
estimates are dominated by BCC incidence, as that is the most
prevalent type of skin cancer. The maximum of the excess
incidence (compared with the “No Depletion” scenario) is in the
following ranges: New Zealand: 100–150, Congo: 10–0, Pata-
gonia: 20–50, Western Europe: 30–40, China: 90–120,
South-West USA: 80–110, Mediterranean: 90–100 and North-
East Australia: 170–200, (in extra cases skin cancer per million
people per year). This is up to 4% of the local total incidence in
the peak year.
The largest excess incidence rates are found for Australia, clo-
sely followed by New Zealand. These countries are relatively
close to the Antarctic ozone hole, where the strongest ozone
depletion is manifested. Figures 1 and 2 show that, for the associ-
ated latitudes in comparison with other latitudes, ozone has just
modest and CMF only marginal development over the observed
period. This excludes the ozone hole from being the cause of the
large excess incidence rate. A factor, that may explain the domi-
nance in Fig. 5 of Australia and New Zealand, is that people from
Australia and New Zealand, with their predominantly white skin,
are relatively sensitive to UV, compared with other people living
in the tropics, and by consequence relatively sensitive to changes
in ozone. Furthermore, they have a high life expectance. This
gives damage inﬂicted by UV the time to mature relatively long
into a malignance, whereas simultaneously the life-integrated
dose of UV received continues to grow. The higher elevation of
the sun in Australia leads to a higher reference rate for the inci-
dence of skin cancer, such that the absolute effect of a small
change in UV index is larger in Australia than in New Zealand.
West EU
South-West USA
Mediterranean
North-East Australia
China
Congo
Patagonia
New Zealand
Figure 4. Regions for which the excess risk at skin cancer is reported.
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Figure 3. Ratio of annual UV dose to UV dose in 1960, estimated with E39C-A. (a) clear-sky dose, (b) cloud-corrected dose, (c) ratio of the graph (b)
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In all cases, the incidence peak is decades later than the peak
in the ozone depletion plus associated UV exposure. The maxi-
mum of the number of new cases of skin cancer is halfway
down the 21st century, when the ozone layer in these calcula-
tions has already recovered. The cause of this delay is that to
become a(n excess-) malignance, any (excess-) damage that is
sustained ﬁrst has to go through some stages of development.
Another cause is that the total damage done by UV will increase
in the course of someone’s life with increased exposure. This
makes skin cancer (partly) a disease that tends to come to
expression later in life.
Uncertainty analysis of risk
For each region, interpixel variations in incidence rates are used
to make an uncertainty analysis. The estimated tolerance thus
reﬂects only one component of uncertainty in the whole chain
from ODS to health risk. In a Monte Carlo procedure, Slaper
et al. (11) have shown that uncertainty in the dose-effect model
parameters makes health-risk assessment associated with ozone
depletion to be an order of magnitude analysis, i.e. up to a scaling
factor in the range 0.1–10. Error estimates for excess health risk
for different regions or scenarios are, however, correlated. This
means that one should project the overall uncertainty in the inte-
grative health assessment on the extent of the vertical scale shown
in risk plots; qualitative characteristics and differences between
scenarios or regions in such plots can still be signiﬁcant.
The attenuation of the UV climate that resulted from the bias
in ozone estimate, does not necessarily affect our risk estimates.
The factors b in the dose–effect relations (given in the Appendix)
are determined by imposing the relations to yield the observed
reference incidence for the reference point. As long as the same
biased UV estimator is used for both the risk assessment in the
scenario analysis and for estimating the multiplicative factors b
via the reference conditions, then any constant bias factor in the
UV estimate is canceled. In case the ozone bias would be lati-
tude dependent, then the consequences for our risk estimates
would still be relatively small. Both the risk calibration and the
majority of the regions with the largest contributions to the
(changes in) risk are found in the northern midlatitudes. Clear
exceptions are Australia and New Zealand.
Risk: taking into account duration and severity of the
diseases life-years lost
Each form of skin cancer entails its own unique loss of quality
of life (see [15] for speciﬁcations). Incidence rates do not take
this into account: they merely count cases. Of all types of skin
cancer, melanoma will contribute the most to the loss of life-
years attributable to ozone depletion (39). As for incidence, the
excess mortality peak will happen halfway this century. At that
time, ozone depletion will cost around eight life years per mil-
lion West-Europeans annually, associated with an annual addi-
tion of around 30 new cases of skin cancer.
RESULTS FOR THE “WORLD AVOIDED”
SCENARIO
Ozone and clouds
Closer inspection of the ozone ﬁelds shows that UKCA, just as
E39C-A, has a high bias leading to overestimation of the total
column ozone.
UV
Absolute and relative differences of the mean year dose UV in
the “World Avoided” when compared with modeled present-day
conditions are presented in Figs. 6 and 7. As can be expected,
the ozone hole above Antarctica is huge for the World Avoided.
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Figure 6. Absolute differences in year dose UV (MJ m2 year1) between the World Avoided and the modeled present-day conditions.
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Figure 5. Excess risk at skin cancer (BCC + SCC + CM) in the Full
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scenario, estimated for eight regions, with 1-sigma intervals based on in-
terpixel variation.
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Our main goal is a risk assessment; as not many people live in
the South Polar region, that part of the world is not shown,
allowing for zooming in on the regional differences in the rest of
the world. The largest relative difference is found near the poles,
but the annual dose in that part of the world is quite small. The
largest absolute difference is (apart from in the South Polar area)
found in the subtropics. People with the most sensitive skin type
live in the midlatitudes and in the north, so the distribution of
the increase in UV spares the more vulnerable groups.
In this study, two different CCMs are used to answer two dif-
ferent questions. To assess the impact of the choice of CCM on
our results, estimates from both models are compared for the
annual, clear-sky UV dose in Fig. 8. For UKCA, the mean value
of the annual dose is used over the whole low chlorine scenario
(3.5 ppbv). For E39C-A, the UV dose in 1997 is taken, when
the chlorine content is the largest: 3 ppbv (see (19), their Fig. 8).
In comparison with UKCA, the E39C-A-dose is relatively low in
the tropics (15%). This is related to the lower chlorine load:
3 ppbv vs 3.5 ppbv. The UV dose is relatively high near the
poles. In the midlatitudes, the two model estimates more or less
agree. The pattern of the differences may partly be related to the
use of a single year for E39C-A. A mean value over, say,
5 years would reduce this source of noise, but then the chlorine
load of the associated contributions would be even lower than
now. Not many people live close to the poles and people in
the tropics tend to have lower UV sensitivity. We therefore do
not expect signiﬁcant impact from model choice on our risk
estimates.
Risk
For the year 2030, the grand total difference in skin cancer inci-
dence between the World Avoided and the Full Compliance sce-
nario’s amounts to two million cases of skin cancer per year,
14% of the total incidence in the “World Avoided” scenario,
that will not appear because the Montreal Protocol and its
amendments have been implemented. Figure 9 shows the geo-
graphic distribution of the number of cases saved per million
local people. The largest peaks are found in the south-west of
the United States of America and in Australia: a prevention of
up to 1500 cases per million people per year, a very large num-
ber. Furthermore, an appreciable gain is shown in Europe, the
United States of America, Canada, Argentina and Russia: an
annual amount of about 600 people per million in these coun-
tries will not develop skin cancer because CFC production and
emissions have been regulated. This is 25% of the total skin
cancer ﬁgure from the UKCA baseline scenario for these regions
for the year 2030.
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Figure 7. Relative differences in year dose UV between the World Avoided and the modeled present-day conditions.
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Figure 8. Ratio of annual clear-sky UV dose for 1997 from E39C-A (3 ppbv) to the mean value of the low chlorine run from UKCA (3.5 ppbv).
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In reality, the “World Avoided” scenario would come about
gradually, so our analysis has its limitations. The analysis has
been made with use of the available climate model runs.
On the one hand, this risk analysis is an order of magnitude
analysis because in reality the change in ozone and health
response function would have happened gradually over many
years. On the other hand, this kind of experiments allows a
clearer attribution of cause and effect.
DISCUSSION AND CONCLUSIONS
What has been the additional value of using CCMs in this study?
The dynamical evolution of the ozone layer is dealt with from
ﬁrst principles, instead of using heuristic parameterizations of
ozone amounts. However, in the comparison of time series for
zonally averaged total column ozone, estimates from Slaper et al.
(11) showed a remarkable resemblance with CCM results.
Despite 25 years since the adoption of the Montreal Protocol and
the evidence that global ODS levels are now declining, there
continues to be observed ozone depletion, with the winter of
2010/2011 actually showing the largest loss in the Arctic on
record (40). Figure 1 shows that the time series for zonally aver-
aged total column ozone exhibits a sufﬁcient amount of oscilla-
tion (e.g. from equatorial quasi-biennial oscillation of the zonal
mean wind) to let this observed arctic ozone hole and our model
remain well in agreement with one another.
Commonly, models have systematic biases with respect to
observations. Here, both models have generally a positive total col-
umn ozone bias for the recent past with respect to satellite observa-
tions from e.g. TOMS. Therefore, continued UV and ozone
observations are required to benchmark models and to scale their
results for impact studies like ours. However, note that the models’
ozone bias does not adversely affect our results because the dose–
effect relations have a functional dependence on UV exposure for
the number of skin cancer cases. These relations are calibrated by
adjustment of a multiplicative constant such that the observed
number of incidences is obtained for present-day conditions.
Den Outer et al. (25) have shown that, for a set of observato-
ries in Europe, the origin of the observed increase in UV dose
has a signature linked to cloud changes. E39C-A demonstrates an
increase in cloud impact, contributing to a declining UV trend.
Model and measurements disagree. A possible explanation is that
observations show a regional brightening in Europe recently,
caused by reduced emissions of SO2. Via a cloud-aerosol feed-
back, this results in a reduction of cloudiness. Global strato-
spheric CCMs generally do not have the physics and chemistry in
place to represent this. It would be interesting to see whether this
effect can be reproduced by the AR5 models (candidates for
evaluation in the Fifth IPCC Assessment Report, scheduled for
2013).
In certain cases, the estimated excess incidence rates become
negative after a while. This is caused by climate change due to
increasing GHG concentrations, which is taken into consideration
in the Full Compliance scenario. This climate change affects
ozone and the CMF. A major factor here is the speedup of the
Brewer–Dobson Circulation, which takes ozone from the tropics
to high latitudes. Correspondingly, there will be less ozone in the
tropics and more in mid- and high latitudes. Superimposed on
that, enhanced GHG concentrations will lead to global warming
of the troposphere (i.e. the greenhouse effect) and to a decrease in
temperature in the stratosphere, thus slowing down the gas phase
photochemical breakdown reactions of ozone. Furthermore,
increasing methane will lead to more stratospheric ozone. In the
reference runs, these dynamical effects are not taken into account,
and consequently these runs do not exhibit the temperature-driven
increase in ozone. In this way, climate change accelerates the
ozone layer recovery and may lead to a super-recovery (10).
Slaper et al. (11) estimated an excess incidence for the Full
Compliance scenario (related to the No Depletion scenario) of
+[25–147] cases per million per year for Western Europe in the
peak year. This corresponds well with the present analysis: +[30
–40] cases per million per year. It must be noted that E39C-A
projects a relatively early ozone recovery in comparison with
other CCMs. An ensemble approach may well support the full
original risk range.
For the World Avoided in 2030 in Southern Australia and
New Zealand, Newman and McKenzie (22, their Fig. 4) estimate
an increase in local noon UV index in summer from 13 to 16
(+23%). This is twice as much as the 10% increase in year dose
that is found with UKCA in Figs. 6 and 7. In consequence, our
estimates for health consequences will be more modest than in
the analysis by Newman and McKenzie. Newman and McKenzie
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Figure 9. Total numbers of new cases of skin cancer per million people per year avoided by the Montreal Protocol in the year 2030.
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erroneously report the mortality for Australia and New Zealand
in the World Avoided too large by a factor of 100. Furthermore,
they use dose–effect relations in a linearized form (variations
around a reference state are estimated via the derivative of the
dose–effect relation), but the reported factor of 3 with which the
peak UV dose for midlatitudes would be changed if the ozone
layer would be depleted to zero, is not “order 1” and therefore
does not allow for a linearized approach: higher order derivatives
play an essential role.
Skin reﬂectivity has shown to provide a good proxy for pro-
tection against skin cancer from UV (see Appendix). In locations
with abundant UV, a darker skin tends to develop than in loca-
tions with low UV. In principle, it is not excluded that this
mechanism can be activated by a changing UV climate, e.g. as a
reaction to ozone depletion, but according to the model by Jab-
lonski and Chaplin (41), this takes many generations. The result
would be a slightly darker skin with lower susceptibility for UV.
There is no scientiﬁc insight yet if the skin works this way. In
addition, it would be possible that this self-adapting UV sensitiv-
ity would lag some time behind the relevant climate changes,
allowing room for the harmful extra UV to ﬁrst induce negative
health implications before it is mitigated by nature. Migration
can lead to a geographic redistribution of skin reﬂectivity over a
much shorter period, but this has been out of our scope.
Many groups are working hard on vitamin D dynamics, but it
was too early for us to include an estimate of the possible aver-
age raise in vitamin D level in blood serum as a reaction to UV
climate hardening induced by ozone depletion. UV can also
induce cataract. Uncertainty in the dose–effect relation has been
considered to be too large to allow for inclusion of cataract in
our account of ozone depletion-related health impact. Struijs
et al. (15) have shown that UV-related cataract may become a
critical problem in the developing countries.
This study is the ﬁrst integrated attempt to use CCM results
in UV radiation and risk models in a full global scenario analy-
sis. Many uncertainties exist, especially with respect to the inﬂu-
ence of the combined effect and mutual interaction between
climate change and ozone depletion and recovery. In addition,
exposure habits can and will change over time and thus inﬂuence
future skin cancer risks. Nevertheless, this study gives a state of
the art scenario analysis of the successes of the Montreal Proto-
col and its amendments in reducing future excess skin cancer
risks associated with global ozone depletion. Models support pol-
icy developments, but continued effort is required to assure full
global compliance of the MP and its amendments. It is also vital
to continue ozone and UV-monitoring in view of the many sci-
entiﬁc uncertainties on the interaction with effects of climate
change. Furthermore, local or regional deviations from the over-
all patterns cannot be excluded.
This study shows that the Montreal Protocol and its amend-
ments have an obvious beneﬁcial effect regarding a clear reduc-
tion in skin cancer risks. Had no countermeasure been taken to
save the ozone layer, then about two more million people per
year would have developed skin cancer by the year 2030, an
increase of 16% worldwide, when compared with the future that
is the result of the Montreal Protocol and its amendments. Esti-
mates for the remaining excess risk, that is associated with the
use of ODSs and that had already been unavoidably committed
when the Montreal Protocol was framed, show a scenario with a
peak in the excess incidence somewhere mid 21st century, the
height of the peak is +2% for E39C-A, followed by recovery or
even super-recovery of ozone and subsequent fall in incidence
rates.
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APPENDIX:
Dose–effect relations for skin cancer
Dose–effect relations for people with a white skin. The dose–
effect relations for skin cancer are used as presented by Slaper
et al. (11) as a basis. These relations give the incidence for basal
cell carcinoma (BCC), squamous cell carcinoma (SCC) and cuta-
neous melanoma (CM) as a function of age a and the available
annual doses of SCUP_h-weighted UV for people with a white
skin (66% skin reﬂectance at 685 nm):
INCðaÞ ¼ YðaÞ  Yða 1Þ
where yield Y (the total number of tumors per million people
observed in a population) is given by (values for coefﬁcients c
and d are given in Table 1):
YSCCðaÞ ¼ bð/ðaÞÞcadc
YBCC;CMðaÞ ¼ b
Xa1
a¼0
DoseðaÞð/ðaÞÞc1ða aÞdc
and where life-integrated UV dose /ðaÞ is given by the sum of
all yearly doses:
/ðaÞ 
Xa1
a¼0
DoseðaÞ
The dose received is assumed to be a ﬁxed fraction of the
available irradiance. Multiplicative factors b are calibrated on the
incidences (per million people per year) in Amsterdam in 1990:
BCC:900, SCC:160, CM:110.
Dose–Effect Relations for Other Locations. Parkin et al. (23)
reported the number of new cases of many types of cancer and
the number of life-years-at-risk for a wide variety of countries
over the world. The incidence rates for skin cancer that can be
constructed from these ﬁgures vary strongly from country to
country. Differences can be due to differences in local sensitiv-
ity, behavior and available UV-dose. Another factor that can lead
to differences in reported incidence rates is underreporting, possi-
bly related to a reduced access to medical care. To account in
our model for the differences in reported incidence rates, we
Table 1. Parameters c and d in the empirical relations for skin cancer.
Type of cancer c d
BCC 1.4 ± 0.4 4.9 ± 0.6
SCC 2.5 ± 0.7 6.6 ± 0.4
CM 0.6 ± 0.4 4.7 ± 1.0
BCC, basal cell carcinoma; SCC, squamous cell carcinoma; CM, cutane-
ous melanoma.
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introduce local dose-reduction factor fp and local underregistra-
tion factor fu, both of which are set to 1 for the reference group
in Amsterdam in 1990. The relation between the dose–effect
model and reported incidence rates for location x is thus:
INCreportedða;Dose;xÞ¼ 1fuðxÞ INCmodel a;
Dose
fpðxÞ
 
¼ 1
fuðxÞf cp ðxÞ
INCmodelða;DoseÞ
From the full set of incidence rates reported by Parkin et al.,
we selected those cancer registry stations that reported incidence
rates for both melanoma and for at least one nonmelanoma of
the skin. For each registry, we estimated the local climatologic
mean SCUP_h-weighted, cloud corrected, year dose UVB and
assumed that this dose has been stationary during the lives of the
people contributing to the incidence ﬁgures. In this way, we cal-
culated local model incidence estimates for melanoma and for
(the reported kind(s) of) nonmelanoma, assuming neither dose
reduction nor underregistration. For each station, the life-years-
at-risk from Parkin et al. is used as population distribution to
construct age-integrated values for both the reported and for the
modeled incidences. Equating modeled and reported age-inte-
grated incidence rates via the above relation leads to a set of two
equations for fp and fu. The nonlinearity in fp makes it possible
to discriminate between dose reduction and incidence reduction
and solve the equations. In this way, we estimated the values for
fp and fu for each station that match model and observation.
Skin Color as a Proxy for Dose Reduction
With the just derived factors fp, we can use our dose–effect rela-
tion for the populations for which the cancer registry bureaus
have given estimates for at least two types of skin cancer. This
is not yet sufﬁcient to construct worldwide estimates for skin
cancer incidence. It has been shown that skins with different skin
color provide different protection against erythema. Clydesdale
et al. (42) report that “Increased melanin production provides
increased protection against the harmful effects of UV exposure,
to the extent that black people with a high melanin content, have
a MED 33-fold higher than their Caucasian counterparts.” Lucas
et al. (39) observe that “intermediate skin types have intermedi-
ate values of protection.” With respect to skin cancer, the inci-
dence rates for subpopulations with a dark skin are way lower
than for the fair-skinned subpopulations in the same area. This
association motivates our suggestion that skin color can be a
measure for protection against skin cancer. This ﬁnding does not
explain why skin color is protective against skin cancer, only
that it is a proxy for protection, whatever the exact nature of the
mechanism. Kollias (43) found that “the photoprotection of epi-
dermal melanin pigmentation is essentially independent of wave-
length,” in other words: skin pigmentation is a gray ﬁlter for UV
radiation. This implies that skin pigmentation does not change
the shape of action spectra and that it gives the same reduction
in the action-spectrum-weighted UV dose for all UV-related
effects that take place below the pigment layer. The skin may
thus use its pigmentation-related protection against sunburn to
also protect against skin cancer. The majority of (BCC + SCC)
cases (often reported together in the incidence data that we used
in our analysis) are related to BCC and both basal cells and mel-
anocytes (involved in CM) reside at the dermal/epidermal junc-
tion. If epidermal melanin pigmentation protects these cells by
deferring a pigmentation-dependent ﬁxed fraction of the incom-
ing UV radiation to locations where less harm can be done, then
one would expect the protection factors for CM and for BCC,
even though a different action spectrum may be involved, to be
the same. In this way, the skin cancer-related dose-reduction fac-
tor can be assumed to be the same for all types of skin cancer.
This is exactly what we did when we estimated dose-reduction
factors fp for each cancer registry. Further elaboration of this
approach requires a worldwide model for local skin color.
We use skin reﬂectances at 685 nm as a measure for skin
color. Local skin reﬂectance is estimated as a linear combination
of the locally available ethnic groups, weighted with their frac-
tional contributions to the local population (44). Original, indige-
nous skin reﬂectance of each ethnic group has been modeled
according to Chaplin and Jablonski (41,45). These predictions
were combined with data on ethnic composition in each country
(44). We estimate the local skin reﬂectances for the cancer regis-
try bureaus for which we estimated fp. The relation between fp
and local skin reﬂectance is presented in Fig. 10a.
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Figure 10. (a) Dose reduction as a function of skin reﬂectance. The line is a ﬁt of the log of the reduction factor as a function of skin reﬂectance forced
through a dose reduction of 1 for 66% skin reﬂectance. (b) Underregistration associated with registry data used for estimation of dose reduction, as a
function of poverty.
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The dashed line shown is the regression curve for log (dose
reduction) as a function of skin reﬂectance, forced through the
calibration of our original model:
fp ¼ 10aðxx0Þ
where x0 = 66 denotes the reference skin reﬂectivity of white
people, whom we set to have a reference protection of one. Thus,
for white Caucasians the generalized dose–effect relations reduce
to the original relations from Slaper et al. By ﬁtting the world-
wide skin cancer incidence data from Parkin et al. (23), we found
a = 0.03935. For dark skin (reﬂectivity 30%), this model gives
a protection factor of fp = 26. This is very similar to the 33-fold
lower MED value reported by Clydesdale et al. (40).
In our analysis, we have used underregistration factor fu. We
still have to check plausibility of the values found. Underregis-
tration is likely to happen when people have reduced access to
medical care. This may be because they live in poverty and can-
not pay for a doctor, or because there are too few doctors avail-
able. We used the data from (44) to construct a poverty measure
as follows:
Poverty ¼ 1=
ð½income per person per year  ½no. physicians per 1000 peopleÞ
The relation between poverty and fu is presented in Fig. 10b.
The lion’s share of the plot is formed by a big cloud of data with
strong correlation between poverty and underregistration. Four
samples for stations with very large poverty have relatively mild
underregistration when compared with the other samples.
Altogether, the above dose–effect relations are now general-
ized to all skin types with a dose-reduction factor fp, accounting
for local UV sensitivity, as a function of skin reﬂectivity x at
685 nm:
Doselocal sensitivity ¼ Dosereference sensitivityfp
fp ¼ 100:03935ðx66Þ
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